Monday 22nd January 2018
|Text too small?|
Blis Technologies reported a positive third quarter result but said that, combined with an ongoing recovery in the fourth quarter, won't offset a tough first half and it lowered full-year guidance.
The Dunedin-based company said revenue for the quarter ended Dec. 31 was $1.6 million, up 6 percent on the year. Earnings before interest, taxes, depreciation and amortisation were $200,000 and there was a small net profit, it said.
Based on known and expected orders for the final quarter Blis is forecasting "ongoing revenue recovery with double-digit growth compared to the same period last year, a positive ebitda and a net profit for the quarter."
However, "this will not be sufficient to fully offset the ebitda loss previously reported for the first half of the year," it said. Blis reported a first-half ebitda loss of $953,000 as trading revenue tumbled, in particular in its North American market.
The company now expects revenue "in excess of $5 million" and an ebitda loss below $500,000, it said.
It did not provide guidance in its first-half report in November, but in October said it expects the company's revenue for the year ending March 31 to be similar to the prior year with a small postive ebitda and a net deficit. Revenue in the prior year was $6.5 million.
Blis was set up to commercialise probiotic bacteria for use in consumer products for oral health, colds and flu, operates in Australasia, Asia, Europe and North America. Its shares last traded at 1.9 cents and have dropped 57 percent over the past 12 months.
No comments yet
NZ shares fell on global growth concerns
New Zealand dollar becalmed ahead of CPI data
Billionaire Aussie miner moves businesses to NZ in 'quixotic' CER gambit
RBNZ plucks bank capital numbers out of the air: Reddell
Genesis coal burn reached 5-yr high in 'unprecedented' conditions
Govt part-funds another $11m of low-emissions transport projects
January 22nd Morning Report
NZ dollar stalled ahead of CPI data; IMF trims global outlook
MARKET CLOSE: NZ stocks gain; investors seek value ahead of earnings season
NZ dollar drifts lower ahead of CPI; China GDP as expected